Translate this page

Weight loss doctor shares his views

Thursday, December 27th, 2012
Issue 52, Volume 16.

TEMECULA - The Village & Valley News asked Dr. Robert Skversky, M.D., of Weight No More in Temecula to share his views on weight loss via a question and answer series. Skversky has over 20 years experience in the medical treatment of overweight/obese individuals and has been featured on numerous television programs. He uses combination drug therapy in addition to diet and exercise on a long term

Basis for control, not cure.


What is the number one falsehood concerning long term weight-loss?


The number one misconception is that diet and exercise actually work for long term weight loss. The truth is they fail miserably for the vast majority of people for good, physiologic reasons. Obesity is a metabolic, chronic, progressive disease with a significant genetic predisposition (as high as 77 percent) very much like diabetes and hypertension. Chronic diseases require pharmacotherapy on a long-term basis for control, not cure.


We have heard that a new drug for weight loss, Qsymia has been approved. Is that true and how effective is it?


Qsymia is a combination of two drugs, phentermine, (an appetite suppressant) and topiramate (anti-seizure) that have been on the U.S. market for many years. Several hundred Advertisement
Advertisement for Berry-Bell and Hall Mortuary
[ Berry-Bell and Hall Mortuary ]
weight-loss physicians have been using the combination, as two separate drugs, for several years and a few of us for well over a decade with great long-term success and safety. Due to strict dosage limitations, Qsymia will be only modestly effective.

In addition, because of potential significant side effects associated with Qsymia, my concern is that physician instruction and patient compliance will not be given the importance necessary for safe and effective use. As a result, the experience of a person’s physician may well be the difference between success and failure.


My doctor told me that phentermine is an amphetamine and should be used for no more than 12 weeks for weight-loss. Is that accurate?


Unfortunately most physicians are misinformed in reference to the appetite suppressant phentermine which is classified as a non-amphetamine schedule IV drug by the FDA. The 12-week labeling was written in the 1970’s and is no longer consistent with current scientific and peer reviewed studies as it applies to phentermine in combination with other medications as part of a long-term maintenance program since 1994.

Questions may be directed to Dr. Skversky at his Temecula office, Weight No More, (951) 699-0848 or visit



arrow Be the first to share your opinion on this article!

Add your Comment


Images, Formatting, or HTML is not allowed : plain text only. You may post up to 5 website addresses within your comment.


The Fallbrook Village News has tightened its' policy regarding comments.
While we invite you to contribute your opinions and thoughts, we request that you refrain from using vulgar or obscene words and post only comments that directly pertain to the specific topic of the story or article.
Comments that are derogatory in nature have a high likelihood for editing or non-approval if they carry the possibility of being libelous.
The comment system is not intended as a forum for individuals or groups to air personal grievances against other individuals or groups.
Please, no advertising or trolling.
In posting a comment for consideration, users understand that their posts may be edited as necessary to meet system parameters, or the post may not be approved at all. By submitting a comment, you agree to all the rules and guidelines described here.
Most comments are approved or disregarded within one business day.

RSS FeedFacebookTwitter

Advertisement for Fallbrook Healthcare Partners


Most Commented

Reach Local Customers

The Fallbrook Village News The Fallbrook Village News
760-723-7319 - 1588 S. Mission Rd. Suite 200, Fallbrook CA 92028
All contents copyright ©2015
About Us
Earthquake Information
Business Listings
Contact Us
Letter to the Editor
Report a website error
Online Digital Edition
RSS Feeds